0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Albendazole Anthelmintic Drug Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-1L14475
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Albendazole Anthelmintic Drug Market Research Report 2023
BUY CHAPTERS

Global Albendazole Anthelmintic Drug Market Research Report 2025

Code: QYRE-Auto-1L14475
Report
July 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Albendazole Anthelmintic Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Albendazole Anthelmintic Drug Market

Albendazole Anthelmintic Drug Market

The global market for Albendazole Anthelmintic Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Albendazole is an anthelmintic drug used to treat parasitic infections caused by various types of worms and helminths. It works by inhibiting the parasites" ability to absorb nutrients, ultimately causing their death. Albendazole is commonly used to treat conditions like intestinal worms, strongyloidiasis, and neurocysticercosis.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Albendazole Anthelmintic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albendazole Anthelmintic Drug.
The Albendazole Anthelmintic Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Albendazole Anthelmintic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Albendazole Anthelmintic Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Albendazole Anthelmintic Drug Market Report

Report Metric Details
Report Name Albendazole Anthelmintic Drug Market
CAGR 5%
Segment by Type
  • Tablet
  • Capsule
  • Other
Segment by Application
  • Human
  • Veterinary
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Huazhong Pharmaceutical, Jiangsu Qihui, Sequent Scientific, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Zhongjia Pharmaceutical, Fredun Pharmaceuticals Ltd, Supharma Chem, Salius Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Albendazole Anthelmintic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Albendazole Anthelmintic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Albendazole Anthelmintic Drug Market report?

Ans: The main players in the Albendazole Anthelmintic Drug Market are GlaxoSmithKline, Huazhong Pharmaceutical, Jiangsu Qihui, Sequent Scientific, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Zhongjia Pharmaceutical, Fredun Pharmaceuticals Ltd, Supharma Chem, Salius Pharma

What are the Application segmentation covered in the Albendazole Anthelmintic Drug Market report?

Ans: The Applications covered in the Albendazole Anthelmintic Drug Market report are Human, Veterinary

What are the Type segmentation covered in the Albendazole Anthelmintic Drug Market report?

Ans: The Types covered in the Albendazole Anthelmintic Drug Market report are Tablet, Capsule, Other

Recommended Reports

Anthelmintic & Antiparasitic

Adjunct Parasitic Therapies

Broader Infectious Diseases

1 Albendazole Anthelmintic Drug Market Overview
1.1 Product Definition
1.2 Albendazole Anthelmintic Drug by Type
1.2.1 Global Albendazole Anthelmintic Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Other
1.3 Albendazole Anthelmintic Drug by Application
1.3.1 Global Albendazole Anthelmintic Drug Market Value by Application (2024 VS 2031)
1.3.2 Human
1.3.3 Veterinary
1.4 Global Albendazole Anthelmintic Drug Market Size Estimates and Forecasts
1.4.1 Global Albendazole Anthelmintic Drug Revenue 2020-2031
1.4.2 Global Albendazole Anthelmintic Drug Sales 2020-2031
1.4.3 Global Albendazole Anthelmintic Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Albendazole Anthelmintic Drug Market Competition by Manufacturers
2.1 Global Albendazole Anthelmintic Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Albendazole Anthelmintic Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Albendazole Anthelmintic Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Albendazole Anthelmintic Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Albendazole Anthelmintic Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Albendazole Anthelmintic Drug, Product Type & Application
2.7 Global Key Manufacturers of Albendazole Anthelmintic Drug, Date of Enter into This Industry
2.8 Global Albendazole Anthelmintic Drug Market Competitive Situation and Trends
2.8.1 Global Albendazole Anthelmintic Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Albendazole Anthelmintic Drug Players Market Share by Revenue
2.8.3 Global Albendazole Anthelmintic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Albendazole Anthelmintic Drug Market Scenario by Region
3.1 Global Albendazole Anthelmintic Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Albendazole Anthelmintic Drug Sales by Region: 2020-2031
3.2.1 Global Albendazole Anthelmintic Drug Sales by Region: 2020-2025
3.2.2 Global Albendazole Anthelmintic Drug Sales by Region: 2026-2031
3.3 Global Albendazole Anthelmintic Drug Revenue by Region: 2020-2031
3.3.1 Global Albendazole Anthelmintic Drug Revenue by Region: 2020-2025
3.3.2 Global Albendazole Anthelmintic Drug Revenue by Region: 2026-2031
3.4 North America Albendazole Anthelmintic Drug Market Facts & Figures by Country
3.4.1 North America Albendazole Anthelmintic Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Albendazole Anthelmintic Drug Sales by Country (2020-2031)
3.4.3 North America Albendazole Anthelmintic Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Albendazole Anthelmintic Drug Market Facts & Figures by Country
3.5.1 Europe Albendazole Anthelmintic Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Albendazole Anthelmintic Drug Sales by Country (2020-2031)
3.5.3 Europe Albendazole Anthelmintic Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Albendazole Anthelmintic Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Albendazole Anthelmintic Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Albendazole Anthelmintic Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Albendazole Anthelmintic Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Albendazole Anthelmintic Drug Market Facts & Figures by Country
3.7.1 Latin America Albendazole Anthelmintic Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Albendazole Anthelmintic Drug Sales by Country (2020-2031)
3.7.3 Latin America Albendazole Anthelmintic Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Albendazole Anthelmintic Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Albendazole Anthelmintic Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Albendazole Anthelmintic Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Albendazole Anthelmintic Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Albendazole Anthelmintic Drug Sales by Type (2020-2031)
4.1.1 Global Albendazole Anthelmintic Drug Sales by Type (2020-2025)
4.1.2 Global Albendazole Anthelmintic Drug Sales by Type (2026-2031)
4.1.3 Global Albendazole Anthelmintic Drug Sales Market Share by Type (2020-2031)
4.2 Global Albendazole Anthelmintic Drug Revenue by Type (2020-2031)
4.2.1 Global Albendazole Anthelmintic Drug Revenue by Type (2020-2025)
4.2.2 Global Albendazole Anthelmintic Drug Revenue by Type (2026-2031)
4.2.3 Global Albendazole Anthelmintic Drug Revenue Market Share by Type (2020-2031)
4.3 Global Albendazole Anthelmintic Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Albendazole Anthelmintic Drug Sales by Application (2020-2031)
5.1.1 Global Albendazole Anthelmintic Drug Sales by Application (2020-2025)
5.1.2 Global Albendazole Anthelmintic Drug Sales by Application (2026-2031)
5.1.3 Global Albendazole Anthelmintic Drug Sales Market Share by Application (2020-2031)
5.2 Global Albendazole Anthelmintic Drug Revenue by Application (2020-2031)
5.2.1 Global Albendazole Anthelmintic Drug Revenue by Application (2020-2025)
5.2.2 Global Albendazole Anthelmintic Drug Revenue by Application (2026-2031)
5.2.3 Global Albendazole Anthelmintic Drug Revenue Market Share by Application (2020-2031)
5.3 Global Albendazole Anthelmintic Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Albendazole Anthelmintic Drug Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Huazhong Pharmaceutical
6.2.1 Huazhong Pharmaceutical Company Information
6.2.2 Huazhong Pharmaceutical Description and Business Overview
6.2.3 Huazhong Pharmaceutical Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Huazhong Pharmaceutical Albendazole Anthelmintic Drug Product Portfolio
6.2.5 Huazhong Pharmaceutical Recent Developments/Updates
6.3 Jiangsu Qihui
6.3.1 Jiangsu Qihui Company Information
6.3.2 Jiangsu Qihui Description and Business Overview
6.3.3 Jiangsu Qihui Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Jiangsu Qihui Albendazole Anthelmintic Drug Product Portfolio
6.3.5 Jiangsu Qihui Recent Developments/Updates
6.4 Sequent Scientific
6.4.1 Sequent Scientific Company Information
6.4.2 Sequent Scientific Description and Business Overview
6.4.3 Sequent Scientific Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sequent Scientific Albendazole Anthelmintic Drug Product Portfolio
6.4.5 Sequent Scientific Recent Developments/Updates
6.5 K.A. Malle Pharmaceuticals
6.5.1 K.A. Malle Pharmaceuticals Company Information
6.5.2 K.A. Malle Pharmaceuticals Description and Business Overview
6.5.3 K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Product Portfolio
6.5.5 K.A. Malle Pharmaceuticals Recent Developments/Updates
6.6 Lasa Supergenerics Limited
6.6.1 Lasa Supergenerics Limited Company Information
6.6.2 Lasa Supergenerics Limited Description and Business Overview
6.6.3 Lasa Supergenerics Limited Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lasa Supergenerics Limited Albendazole Anthelmintic Drug Product Portfolio
6.6.5 Lasa Supergenerics Limited Recent Developments/Updates
6.7 Zhongjia Pharmaceutical
6.7.1 Zhongjia Pharmaceutical Company Information
6.7.2 Zhongjia Pharmaceutical Description and Business Overview
6.7.3 Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Product Portfolio
6.7.5 Zhongjia Pharmaceutical Recent Developments/Updates
6.8 Fredun Pharmaceuticals Ltd
6.8.1 Fredun Pharmaceuticals Ltd Company Information
6.8.2 Fredun Pharmaceuticals Ltd Description and Business Overview
6.8.3 Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Product Portfolio
6.8.5 Fredun Pharmaceuticals Ltd Recent Developments/Updates
6.9 Supharma Chem
6.9.1 Supharma Chem Company Information
6.9.2 Supharma Chem Description and Business Overview
6.9.3 Supharma Chem Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Supharma Chem Albendazole Anthelmintic Drug Product Portfolio
6.9.5 Supharma Chem Recent Developments/Updates
6.10 Salius Pharma
6.10.1 Salius Pharma Company Information
6.10.2 Salius Pharma Description and Business Overview
6.10.3 Salius Pharma Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Salius Pharma Albendazole Anthelmintic Drug Product Portfolio
6.10.5 Salius Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Albendazole Anthelmintic Drug Industry Chain Analysis
7.2 Albendazole Anthelmintic Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Albendazole Anthelmintic Drug Production Mode & Process Analysis
7.4 Albendazole Anthelmintic Drug Sales and Marketing
7.4.1 Albendazole Anthelmintic Drug Sales Channels
7.4.2 Albendazole Anthelmintic Drug Distributors
7.5 Albendazole Anthelmintic Drug Customer Analysis
8 Albendazole Anthelmintic Drug Market Dynamics
8.1 Albendazole Anthelmintic Drug Industry Trends
8.2 Albendazole Anthelmintic Drug Market Drivers
8.3 Albendazole Anthelmintic Drug Market Challenges
8.4 Albendazole Anthelmintic Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Albendazole Anthelmintic Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Albendazole Anthelmintic Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Albendazole Anthelmintic Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Albendazole Anthelmintic Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Albendazole Anthelmintic Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Albendazole Anthelmintic Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Albendazole Anthelmintic Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Albendazole Anthelmintic Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Albendazole Anthelmintic Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Albendazole Anthelmintic Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Albendazole Anthelmintic Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Albendazole Anthelmintic Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Albendazole Anthelmintic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albendazole Anthelmintic Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Albendazole Anthelmintic Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Albendazole Anthelmintic Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Albendazole Anthelmintic Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Albendazole Anthelmintic Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Albendazole Anthelmintic Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Albendazole Anthelmintic Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Albendazole Anthelmintic Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Albendazole Anthelmintic Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Albendazole Anthelmintic Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Albendazole Anthelmintic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Albendazole Anthelmintic Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Albendazole Anthelmintic Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Albendazole Anthelmintic Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Albendazole Anthelmintic Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Albendazole Anthelmintic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Albendazole Anthelmintic Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Albendazole Anthelmintic Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Albendazole Anthelmintic Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Albendazole Anthelmintic Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Albendazole Anthelmintic Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Albendazole Anthelmintic Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Albendazole Anthelmintic Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Albendazole Anthelmintic Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Albendazole Anthelmintic Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Albendazole Anthelmintic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Albendazole Anthelmintic Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Albendazole Anthelmintic Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Albendazole Anthelmintic Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Albendazole Anthelmintic Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Albendazole Anthelmintic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Albendazole Anthelmintic Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Albendazole Anthelmintic Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Albendazole Anthelmintic Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Albendazole Anthelmintic Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Albendazole Anthelmintic Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Albendazole Anthelmintic Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Albendazole Anthelmintic Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Albendazole Anthelmintic Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Albendazole Anthelmintic Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Albendazole Anthelmintic Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Albendazole Anthelmintic Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Albendazole Anthelmintic Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Albendazole Anthelmintic Drug Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Albendazole Anthelmintic Drug Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Albendazole Anthelmintic Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Albendazole Anthelmintic Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Albendazole Anthelmintic Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Albendazole Anthelmintic Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Albendazole Anthelmintic Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Albendazole Anthelmintic Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Albendazole Anthelmintic Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Albendazole Anthelmintic Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Albendazole Anthelmintic Drug Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Albendazole Anthelmintic Drug Price (US$/Unit) by Application (2026-2031)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Albendazole Anthelmintic Drug Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. Huazhong Pharmaceutical Company Information
 Table 76. Huazhong Pharmaceutical Description and Business Overview
 Table 77. Huazhong Pharmaceutical Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Huazhong Pharmaceutical Albendazole Anthelmintic Drug Product
 Table 79. Huazhong Pharmaceutical Recent Developments/Updates
 Table 80. Jiangsu Qihui Company Information
 Table 81. Jiangsu Qihui Description and Business Overview
 Table 82. Jiangsu Qihui Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Jiangsu Qihui Albendazole Anthelmintic Drug Product
 Table 84. Jiangsu Qihui Recent Developments/Updates
 Table 85. Sequent Scientific Company Information
 Table 86. Sequent Scientific Description and Business Overview
 Table 87. Sequent Scientific Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Sequent Scientific Albendazole Anthelmintic Drug Product
 Table 89. Sequent Scientific Recent Developments/Updates
 Table 90. K.A. Malle Pharmaceuticals Company Information
 Table 91. K.A. Malle Pharmaceuticals Description and Business Overview
 Table 92. K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Product
 Table 94. K.A. Malle Pharmaceuticals Recent Developments/Updates
 Table 95. Lasa Supergenerics Limited Company Information
 Table 96. Lasa Supergenerics Limited Description and Business Overview
 Table 97. Lasa Supergenerics Limited Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Lasa Supergenerics Limited Albendazole Anthelmintic Drug Product
 Table 99. Lasa Supergenerics Limited Recent Developments/Updates
 Table 100. Zhongjia Pharmaceutical Company Information
 Table 101. Zhongjia Pharmaceutical Description and Business Overview
 Table 102. Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Product
 Table 104. Zhongjia Pharmaceutical Recent Developments/Updates
 Table 105. Fredun Pharmaceuticals Ltd Company Information
 Table 106. Fredun Pharmaceuticals Ltd Description and Business Overview
 Table 107. Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Product
 Table 109. Fredun Pharmaceuticals Ltd Recent Developments/Updates
 Table 110. Supharma Chem Company Information
 Table 111. Supharma Chem Description and Business Overview
 Table 112. Supharma Chem Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Supharma Chem Albendazole Anthelmintic Drug Product
 Table 114. Supharma Chem Recent Developments/Updates
 Table 115. Salius Pharma Company Information
 Table 116. Salius Pharma Description and Business Overview
 Table 117. Salius Pharma Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Salius Pharma Albendazole Anthelmintic Drug Product
 Table 119. Salius Pharma Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Albendazole Anthelmintic Drug Distributors List
 Table 123. Albendazole Anthelmintic Drug Customers List
 Table 124. Albendazole Anthelmintic Drug Market Trends
 Table 125. Albendazole Anthelmintic Drug Market Drivers
 Table 126. Albendazole Anthelmintic Drug Market Challenges
 Table 127. Albendazole Anthelmintic Drug Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Albendazole Anthelmintic Drug
 Figure 2. Global Albendazole Anthelmintic Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Albendazole Anthelmintic Drug Market Share by Type: 2024 & 2031
 Figure 4. Tablet Product Picture
 Figure 5. Capsule Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Albendazole Anthelmintic Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Albendazole Anthelmintic Drug Market Share by Application: 2024 & 2031
 Figure 9. Human
 Figure 10. Veterinary
 Figure 11. Global Albendazole Anthelmintic Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Albendazole Anthelmintic Drug Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Albendazole Anthelmintic Drug Sales (2020-2031) & (K Units)
 Figure 14. Global Albendazole Anthelmintic Drug Average Price (US$/Unit) & (2020-2031)
 Figure 15. Albendazole Anthelmintic Drug Report Years Considered
 Figure 16. Albendazole Anthelmintic Drug Sales Share by Manufacturers in 2024
 Figure 17. Global Albendazole Anthelmintic Drug Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Albendazole Anthelmintic Drug Players: Market Share by Revenue in Albendazole Anthelmintic Drug in 2024
 Figure 19. Albendazole Anthelmintic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Albendazole Anthelmintic Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Albendazole Anthelmintic Drug Sales Market Share by Country (2020-2031)
 Figure 22. North America Albendazole Anthelmintic Drug Revenue Market Share by Country (2020-2031)
 Figure 23. United States Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Albendazole Anthelmintic Drug Sales Market Share by Country (2020-2031)
 Figure 26. Europe Albendazole Anthelmintic Drug Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Albendazole Anthelmintic Drug Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Albendazole Anthelmintic Drug Revenue Market Share by Region (2020-2031)
 Figure 34. China Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Albendazole Anthelmintic Drug Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Albendazole Anthelmintic Drug Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Albendazole Anthelmintic Drug Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Albendazole Anthelmintic Drug Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Albendazole Anthelmintic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Albendazole Anthelmintic Drug by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Albendazole Anthelmintic Drug by Type (2020-2031)
 Figure 55. Global Albendazole Anthelmintic Drug Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Albendazole Anthelmintic Drug by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Albendazole Anthelmintic Drug by Application (2020-2031)
 Figure 58. Global Albendazole Anthelmintic Drug Price (US$/Unit) by Application (2020-2031)
 Figure 59. Albendazole Anthelmintic Drug Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS